Disulfiram-like	disulfiram-like	O	O	O	O
syndrome	syndrome	O	O	O	O
after	after	O	O	O	O
hydrogen	hydrogen	O	O	OTHERS	I
cyanamide	cyanamide	O	O	OTHERS	I
professional	professional	O	O	O	O
skin	skin	O	O	O	O
exposure	exposure	O	O	O	O
:	:	O	O	O	O
two	two	O	O	O	O
case	case	O	O	O	O
reports	reports	O	O	O	O
in	in	O	O	O	O
France	france	O	O	O	O
.	.	O	O	O	O

Hydrogen	hydrogen	O	O	OTHERS	I
cyanamide	cyanamide	O	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
plant	plant	O	O	O	O
growth	growth	O	O	O	O
regulator	regulator	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
agriculture	agriculture	O	O	O	O
to	to	O	O	O	O
induce	induce	O	O	O	O
bud	bud	O	O	O	O
break	break	O	O	O	O
in	in	O	O	O	O
fruit	fruit	O	O	O	O
trees	trees	O	O	O	O
.	.	O	O	O	O

Contact	contact	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
skin	skin	O	O	O	O
can	can	O	O	O	O
result	result	O	O	O	O
in	in	O	O	O	O
percutaneous	percutaneous	O	O	O	O
absorption	absorption	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
substance	substance	O	O	O	O
that	that	O	O	O	O
inhibits	inhibits	O	O	O	O
aldehyde	aldehyde	CHEMICALS	O	OTHERS	I
dehydrogenase	dehydrogenase	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
can	can	O	O	O	O
induce	induce	O	O	O	O
acetaldehyde	acetaldehyde	O	O	OTHERS	I
syndrome	syndrome	O	O	O	O
in	in	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
alcohol	alcohol	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
purpose	purpose	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
report	report	O	O	O	O
is	is	O	O	O	O
to	to	O	O	O	O
describe	describe	O	O	O	O
two	two	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
disulfiram-like	disulfiram-like	O	O	O	O
syndrome	syndrome	O	O	O	O
following	following	O	O	O	O
occupational	occupational	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
hydrogen	hydrogen	O	O	OTHERS	I
cyanamide	cyanamide	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
first	first	O	O	O	O
case	case	O	O	O	O
involved	involved	O	O	O	O
a	a	O	O	O	O
59-year-old	59-year-old	O	O	O	O
man	man	O	O	O	O
who	who	O	O	O	O
used	used	O	O	O	O
Dormex	dormex	O	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
contains	contains	O	O	O	O
hydrogen	hydrogen	O	O	OTHERS	I
cyanamide	cyanamide	O	O	OTHERS	I
,	,	O	O	O	O
without	without	O	O	O	O
protection	protection	O	O	O	O
after	after	O	O	O	O
consuming	consuming	O	O	O	O
a	a	O	O	O	O
large	large	O	O	O	O
amount	amount	O	O	O	O
of	of	O	O	O	O
alcohol	alcohol	CHEMICALS	O	OTHERS	I
during	during	O	O	O	O
a	a	O	O	O	O
meal	meal	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
1	1	O	O	O	O
hour	hour	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
ingestion	ingestion	O	O	O	O
of	of	O	O	O	O
alcohol	alcohol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
he	he	O	O	O	O
developed	developed	O	O	O	O
malaise	malaise	O	O	OTHERS	I
with	with	O	O	O	O
flushing	flushing	O	O	OTHERS	I
of	of	O	O	OTHERS	I
the	the	O	O	OTHERS	I
face	face	O	O	OTHERS	I
,	,	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
dyspnea	dyspnea	O	O	OTHERS	I
.	.	O	O	O	O

Manifestations	manifestations	O	O	O	O
regressed	regressed	O	O	O	O
spontaneously	spontaneously	O	O	O	O
under	under	O	O	O	O
surveillance	surveillance	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
hospital	hospital	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
second	second	O	O	O	O
case	case	O	O	O	O
occurred	occurred	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
55-year-old	55-year-old	O	O	O	O
farmer	farmer	O	O	O	O
following	following	O	O	O	O
cutaneous	cutaneous	O	O	O	O
contact	contact	O	O	O	O
with	with	O	O	O	O
Dormex	dormex	O	O	OTHERS	I
.	.	O	O	O	O

Five	five	O	O	O	O
hours	hours	O	O	O	O
after	after	O	O	O	O
exposure	exposure	O	O	O	O
,	,	O	O	O	O
he	he	O	O	O	O
developed	developed	O	O	O	O
disulfiram-like	disulfiram-like	O	O	O	O
syndrome	syndrome	O	O	O	O
with	with	O	O	O	O
flushing	flushing	O	O	OTHERS	I
,	,	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
arterial	arterial	O	O	OTHERS	I
hypotension	hypotension	O	DISEASE	OTHERS	I
after	after	O	O	O	O
consuming	consuming	O	O	O	O
three	three	O	O	O	O
glasses	glasses	O	O	O	O
of	of	O	O	O	O
wine	wine	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
recovered	recovered	O	O	O	O
spontaneously	spontaneously	O	O	O	O
in	in	O	O	O	O
3	3	O	O	O	O
hours	hours	O	O	O	O
under	under	O	O	O	O
surveillance	surveillance	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
hospital	hospital	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
cases	cases	O	O	O	O
confirm	confirm	O	O	O	O
the	the	O	O	O	O
necessity	necessity	O	O	O	O
of	of	O	O	O	O
avoiding	avoiding	O	O	O	O
alcohol	alcohol	CHEMICALS	O	OTHERS	I
consumption	consumption	O	O	O	O
as	as	O	O	O	O
recommended	recommended	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
instructions	instructions	O	O	O	O
for	for	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
Dormex	dormex	O	O	OTHERS	I
and	and	O	O	O	O
of	of	O	O	O	O
preventing	preventing	O	O	O	O
cutaneous	cutaneous	O	O	O	O
contact	contact	O	O	O	O
during	during	O	O	O	O
use	use	O	O	O	O
.	.	O	O	O	O

